US pharma major Eli Lilly shares closed up 2.8%, while those of Adverum Biotechnologies dropped 2.4% to $4.28, on news of a ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved the medicine Alhemo (concizumab) to prevent or ...

The US Food and Drug Administration (FDA) has approved UK pharma major GSK’s Blenrep belantamab mafodotin-blmf) in ...

UK regulators have dismantled a major illicit operation producing unlicensed weight loss medicines, following a raid on a ...

US healthcare giant Johnson & Johnson today announced that the European Commission (EC) has approved the expansion for the marketing authorization for Tremfya (guselkumab) to include a subcutaneous ...

The UK’s National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending the use of ...

US biotech major Biogen and Chicago, Canada-based Vanqua Bio today announced a license agreement granting Biogen exclusive ...

San Diego-based inflammatory diseases specialist Ventyx Biosciences announced positive results from its Phase II study of ...

Japan’s Mitsubishi Tanabe Pharma (MTPC) yesterday announced that the US Food and Drug Administration (FDA) has issued a ...

US clinical-stage biotech Tango Therapeutics has announced the pricing of an underwritten offering of 21,023,337 shares of ...

French pharma major Sanofi (Euronext: SAN) reported third-quarter 2025 revenue of 12.4 billion euros ($13.2 billion), up 7% ...